For online access please click this link just before the start of the webinar.
It is now recognised that airway epithelium plays a central role in immunity. Many lung diseases can trace their origins to airway epithelium. In this talk, Professor Bartlett will discuss research that has focused on leveraging epithelial cell anti-microbial innate immunity to prevent respiratory viral disease or blocking pro-inflammatory/pro-fibrotic processes for diseases such as asthma and idiopathic pulmonary fibrosis.
Professor Nathan Bartlett
Professor Bartlett has over 20 years of experience working in respiratory viral immunology, pathogenesis of virus induced respiratory diseases and drug and vaccine development. After completing post-doctoral research, first at the University of Oxford and then Imperial College London, he began investigating rhinovirus and coronavirus infections and exacerbations of asthma, chronic obstructive pulmonary disease and pulmonary fibrosis.
Opinions expressed by individuals at this event are solely of those of the individual/s and do not necessarily represent the views or opinions of the Kirby Institute or UNSW.